The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17’s unique signaling pathways to offer more targeted and cost-effective treatments.
Drug pricing and the ‘impossible trinity’ for patients
You don’t have to be an economist to understand the law of demand: The higher the price, the less likely a customer is to buy
July 24, 2023